SGLT2 Inhibitors Outperform DPP-4 Inhibitors in Safety for Super-Elderly Diabetic Patients
A large propensity score-matched study reveals that super-elderly diabetes patients initiating SGLT2 inhibitors experienced significantly fewer falls, fractures, and kidney ...




















